+306.5%
SN vs BBIO
+154.4%
+152.0%
-42.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | -0.1% | -1.0% | -1.1% |
| 7D | -7.3% | -3.2% | -4.0% | -6.7% |
| 30D | -13.6% | -13.6% | 0.0% | -11.2% |
| 3M | +18.6% | +7.2% | +11.4% | +16.4% |
| 6M | +46.0% | +1.5% | +44.5% | +44.7% |
| YTD | +43.7% | -5.3% | +49.0% | +43.6% |
| 1Y | +39.2% | +37.7% | +1.5% | +29.6% |
| 3Y | +306.5% | +153.9% | +152.6% | +223.9% |
| All | +306.5% | +154.4% | +152.0% | +223.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling